Loading clinical trials...
Loading clinical trials...
A Phase III, Multicentre, Prospective, Open Label Extension Study to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injections Used for the Treatment of Upper Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Conditions
Interventions
Botulinum toxin type A
Locations
34
United States
Rancho Los Amigos National Rehabilitation Center
Downey, California, United States
Associated Neurologist of Southern CT, PT
Fairfield, Connecticut, United States
Parkinson's Disease & Movement Disorders Center of Boca Raton
Boca Raton, Florida, United States
Design Neuroscience Miami
South Miami, Florida, United States
The Rehabilitation Institute of Chicago
Chicago, Illinois, United States
Mount Sinai School of Medicine
New York, New York, United States
Start Date
November 1, 2011
Primary Completion Date
December 1, 2014
Completion Date
December 1, 2014
Last Updated
September 28, 2022
NCT02338466
NCT02050854
Lead Sponsor
Ipsen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions